title: [Use of sulprostone in nulliparous patients in voluntary interruption of pregnancy during the first trimester].
abstract: A new PGE2 derivate, sulprostone, is described in detail. The drug was used to induce abortion in 68 patients in the first three months of pregnancy. It was administered intramuscularly, in a single dose of 500 mcg. The results obtained clearly reveal sulprostone to be an effective drug, easily handled and well tolerated.
authors.forename: L
authors.initials: L
authors.lastname: Cipolla
authors.forename: A
authors.initials: A
authors.lastname: Gonfiantini
authors.forename: G
authors.initials: G
authors.lastname: Giannetta
mesh_terms: D000019:Abortifacient Agents; D000020:Abortifacient Agents, Nonsteroidal; D000028:Abortion, Induced; D000293:Adolescent; D000328:Adult; D002584:Cervix Uteri / Q000187:drug effects; D002986:Clinical Trials as Topic; D015232:Dinoprostone / Q000031:analogs & derivatives*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D010298:Parity; D011247:Pregnancy; D011261:Pregnancy Trimester, First
chemical_list: D000019:Abortifacient Agents; D000020:Abortifacient Agents, Nonsteroidal; C016767:sulprostone; D015232:Dinoprostone
vernacular_title: Uso del sulprostone in pazienti nullipare nel corso di I.V.G. del primo trimestre.